N. Sutton

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Nguyen H. Tran, Vidyashankara G. Iyer, Andreas C. Themistocleous, 2020, Lancet.

Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6–17 years: a preliminary report of COV006, a phase 2 single-blind, randomised, controlled trial

A. Pollard, P. Aley, L. Godfrey, 2022, The Lancet.

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials

Nguyen H. Tran, Vidyashankara G. Iyer, Andreas C. Themistocleous, 2021, The Lancet.

Comparing reactogenicity of COVID-19 vaccines: a systematic review and meta-analysis

Y. Hsia, P. Heath, E. Galiza, 2022, Expert review of vaccines.

Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines: an exploratory substudy of a randomised, observer-blinded, placebo-controlled, phase 3 trial

Adam C. Champion, Jane E. Ewing, M. Elnaggar, 2021, The Lancet Respiratory Medicine.

Predicting IVIG resistance in UK Kawasaki disease

C. Hoggart, M. Levin, J. Herberg, 2015, Archives of Disease in Childhood.